½ÃÀ庸°í¼­
»óǰÄÚµå
1803114

¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå ¿¹Ãø(-2032³â) : Á¾·ùº°, Á¦Çüº°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Glufosinate Market Forecasts to 2032 - Global Analysis By Type (Technical Concentrate (TC), Technical Grade (TK) and Other Types), Formulation, Distribution Channel, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀåÀº 2025³â¿¡ 30¾ï 3,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, 2032³â¿¡´Â 69¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 12.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

±Û·çÆ÷½Ã³×ÀÌÆ®´Â °ÜÀÚ, ºê·ÎÄݸ®, ¾ç¹èÃß µîÀÇ ½Ä¹°¿¡ ÇÔÀ¯µÈ õ¿¬ À¯·¡ ÇÔȲ È­ÇÕ¹°ÀÎ ±Û·çÄڽóÀÌÆ®¿¡¼­ À¯·¡ÇÑ È­ÇÕ¹°±ºÀ» ¸»ÇÕ´Ï´Ù. À̵é È­ÇÕ¹°Àº ÁÖ·Î »ìÃæ Ȱ¼º, Á¦ÃÊ È°¼º µîÀÇ »ý¸®È°¼º Ư¼ºÀÌ ÀÎÁ¤µÇ¾î ³ó¾÷ ¹× ÀÛ¹° º¸È£¿¡ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. È¿¼Ò¿¡ ÀÇÇÑ °¡¼öºÐÇØ¸¦ °ÅÄ¡¸é ±Û·çÄڽóÀÌÆ®´Â ±Û·çÆ÷½Ã³×ÀÌÆ® ¹× °ü·Ã È­ÇÕ¹°·Î º¯È­ÇÏ¿© ÇØÃæ°ú º´¿ø±ÕÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±Û·çÆ÷½Ã³×ÀÌÆ®ÀÇ ¿ªÇÒÀº ³ó¾÷, Á¦¾à, ½Äǰ »ê¾÷ µî ´Ù¹æ¸é¿¡ °ÉÃÄ ÀÖÀ¸¸ç, ±× ´Ù±â´ÉÀûÀÎ ¿ëµµ°¡ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

Á¦ÃÊÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

³óºÎµéÀº ÀÛ¹° ¼öÈ®·®À» º¸È£Çϱâ À§ÇØ È¿°úÀûÀÎ ÀâÃÊ ¹æÁ¦ ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. ±Û·çÆ÷½Ã³×ÀÌÆ®´Â ±¤¹üÀ§ÇÑ ½ºÆåÆ®·³À» °¡Áø Á¦ÃÊÁ¦À̱⠶§¹®¿¡ ÀÌ·¯ÇÑ ¼ö¿ä¿¡ È¿À²ÀûÀ¸·Î ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ³ó¾÷ Ȱµ¿ÀÇ È®´ë´Â ±Û·çÆ÷½Ã³×ÀÌÆ®ÀÇ ¼Òºñ¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼Ó°¡´ÉÇϰí ÀÜ·ù¹° ¾ø´Â ÀÛ¹° º¸È£¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±× äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ÀÌ·¯ÇÑ ¿äÀεéÀº ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

³ôÀº Á¦Á¶ ºñ¿ë

Á¦Á¶ ºñ¿ëÀÇ »ó½ÂÀº »ý»êÀÚÀÇ ÀÌÀ±À²À» ³·Ãß°í, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ Á¦ÇÑÇÕ´Ï´Ù. Áß¼Ò±â¾÷Àº ³ôÀº ºñ¿ëÀÌ À庮ÀÌ µÇ¾î °æÀï¿¡¼­ ½Â¸®Çϱ⠾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ³ôÀº ºñ¿ëÀº ¶ÇÇÑ ³óºÎµéÀÌ ±Û·çÆ÷½Ã³×ÀÌÆ® »ç¿ëÀ» ²¨¸®°Ô ÇÏ¿© ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. °¡°Ý¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼­´Â ´õ Àú·ÅÇÑ ´ëü Á¦ÃÊÁ¦·Î ÀüȯÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±× °á°ú, ½ÃÀåÀÇ È®´ë¿Í ¼ºÀåÀÌ µÐÈ­µÇ¾î Àüü ½ÃÀåÀÇ ÀáÀç·ÂÀÌ Á¦Çѵ˴ϴÙ.

Áö¼Ó°¡´ÉÇÑ ³ó¾÷À¸·ÎÀÇ Àüȯ

³óºÎµéÀº ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̱â À§ÇØ Ä£È¯°æ Á¦ÃÊÁ¦¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º ¹× Åä¾ç ÀÜ·ù¼ºÀÌ ³·Àº ±Û·çÆ÷½Ã³×ÀÌÆ®´Â ÀÌ·¯ÇÑ Áö¼Ó°¡´É¼º ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¦Ç°ÀÔ´Ï´Ù. ±ÔÁ¦ ±â°üÀÌ ½Äǰ°ú Åä¾ç¿¡ ÀÜ·ùÇÏ´Â È­ÇÐÁ¦Ç°ÀÇ Àú°¨È­¸¦ ÃßÁøÇÔ¿¡ µû¶ó ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯±â³ó¹ýÀ̳ª Á¾ÇÕ³ó¹ý¿¡¼­´Â º¸´Ù ¾ÈÀüÇÑ ´ëü Á¦ÃÊÁ¦ »ç¿ëÀ» ±ÇÀåÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀåÀº Àü ¼¼°èÀûÀ¸·Î ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

´ëü ¾àǰÀÇ °¡¿ë¼º

³óºÎµéÀº ³Î¸® ¾²ÀÌ´Â ´Ù¸¥ Á¦ÃÊÁ¦°¡ ´õ Àú·ÅÇϰųª ƯÁ¤ ÀâÃÊ¿¡ ´õ È¿°úÀûÀ̱⠶§¹®¿¡ ±×ÂÊÀ» ¼±È£ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ´ëüǰÀº ±Û·çÆ÷½Ã³×ÀÌÆ® ±â¹Ý Á¦Ç°ÀÇ ¼ö¿ä¸¦ °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °æÀï Á¦ÃÊÁ¦ÀÇ ±âÁ¸ ºê·£µå´Â °­·ÂÇÑ ½ÃÀå Ãæ¼ºµµ¸¦ ÅëÇØ ÀÌÀÍÀ» ¾ò°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ´Ù¸¥ È­ÇÐÁ¦Ç°¿¡ ´ëÇÑ Àͼ÷ÇÔÀ¸·Î ÀÎÇØ ÃÖÁ¾»ç¿ëÀÚ°¡ ½±°Ô ÀüȯÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¿©·¯ ´ëüǰÀÇ Á¸Àç´Â ±Û·çÆ÷½Ã³×ÀÌÆ®ÀÇ ½ÃÀå ¼ºÀå°ú äÅÃÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19´Â ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀåÀ» Å©°Ô È¥¶õ¿¡ ºü¶ß·È°í, °ø±Þ¸Á°ú ¼ö¿ä ÆÐÅÏ ¸ðµÎ¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ºÀ¼â¿Í ±ÔÁ¦·Î ÀÎÇØ ¿øÀÚÀç »ý»ê°ú ¹°·ù°¡ Áö¿¬µÇ¾î ÀϽÃÀûÀÎ ºÎÁ· Çö»óÀÌ ¹ß»ýÇß½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚÀÎ ³ó¾÷ ºÎ¹®°ú »ê¾÷ ºÎ¹®Àº ¿î¿µ»óÀÇ ¾î·Á¿ò¿¡ Á÷¸éÇÏ¿© ´çºÐ°£ ¼Òºñ°¡ °¨¼ÒÇß½À´Ï´Ù. ¶ÇÇÑ, ÇʼöÀûÀÎ ÀÇ·á ¹× ½Ä·® ¾Èº¸¿¡ ´ëÇÑ Á¤ºÎÀÇ ¿ì¼±¼øÀ§°¡ ¹Ù²î¸é¼­ ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁÂÀý¿¡µµ ºÒ±¸Çϰí, ÆÒµ¥¹ÍÀº ±Û·çÆ÷½Ã³×ÀÌÆ®¿Í °°Àº ź·ÂÀûÀ̰í ģȯ°æÀûÀÎ Á¦ÃÊÁ¦¿¡ ´ëÇÑ °ü½ÉÀ» ºÒ·¯ÀÏÀ¸Ä×½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î COVID-19´Â ÀϽÃÀûÀ¸·Î ¼ºÀåÀ» µÐÈ­½ÃÄ×Áö¸¸, ½ÃÀå¿¡¼­ÀÇ ÀûÀÀ·Â°ú Áö¼Ó°¡´ÉÇÑ °üÇàÀÇ Çʿ伺À» °­Á¶Çß½À´Ï´Ù.

±â¼ú ³óÃàÁ¦(TC) ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼ú ³óÃ๰(TC) ºÎ¹®Àº Á¦ÃÊÁ¦¿Í °°Àº ÃÖÁ¾ ¿ëµµ Á¦Ç°À¸·Î Á¦ÇüÈ­Çϱâ À§ÇÑ ÁÖ¿ä ¿ø·á·Î ÀÛ¿ëÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. TC´Â ³ôÀº ¼øµµ¿Í È¿´ÉÀ» º¸ÀåÇϰí ÀÛ¹° º¸È£ ¼º´É°ú ³ó°¡ÀÇ ½Å·Ú¸¦ ³ôÀÔ´Ï´Ù. TC´Â À¯¿¬ÇÑ È¥ÇÕ°ú ¹èÇÕÀ» °¡´ÉÇÏ°Ô ÇÏ¿© Áö¿ª °£ ´Ù¾çÇÑ ³ó¾÷ ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù. »ý»ê ±Ô¸ð´Â ºñ¿ë È¿À²¼ºÀ» µÞ¹ÞħÇÏ°í ±Û·çÆ÷½Ã³×ÀÌÆ® Á¦Ç°ÀÇ ±¹Á¦ °æÀï·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. TCÀÇ Ç°Áú¿¡ ´ëÇÑ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀº ±× äÅÃÀ» ´õ¿í È®´ëÇÏ¿© Àüü ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

°íÇüÁ¦ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °íü Á¦Á¦ ºÐ¾ß´Â ¾×ü Á¦Á¦¿¡ ºñÇØ Ãë±Þ, º¸°ü, ¿î¼ÛÀÌ ¿ëÀÌÇÏ¿© °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °íÇü Á¦Á¦´Â Á¤È®ÇÑ Åõ¾àÀÌ °¡´ÉÇϰí À¯Åë±âÇÑÀÌ ±æ¾î ³ó°¡¿Í À¯Åë¾÷ü¿¡°Ô ¸Å·ÂÀûÀÔ´Ï´Ù. °ú¸³À̳ª ºÐ¸»°ú °°Àº °íü ÇüÅ´ »ìÆ÷ È¿À²À» ³ôÀ̰í ȯ°æ À¯ÃâÀ» ÁÙÀÔ´Ï´Ù. ÀÌ ºÎ¹®Àº ¾×ü »ìÆ÷°¡ ¾î·Á¿î ¹° ºÎÁ· Áö¿ª¿¡¼­ÀÇ Ã¤ÅÃÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ±× Æí¸®¼º, ¾ÈÁ¤¼º, À¯È¿¼ºÀÌ ½ÃÀåÀÇ ¼ö¿ä¿Í ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À² Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â À¯ÀüÀÚ º¯Çü ÀÛ¹°ÀÇ Ã¤ÅÃÀÌ ¸¹±â ¶§¹®ÀÔ´Ï´Ù. ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ´Â ¿Á¼ö¼ö, ´ëµÎ, Ä«³î¶ó Àç¹è¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, È¿°úÀûÀÎ Á¦ÃÊÁ¦¿¡ ´ëÇÑ °­·ÂÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. Áö¼Ó°¡´ÉÇÑ ³ó¾÷, Á¾ÇÕÀûÀÎ ÇØÃæ °ü¸®, ÀÚµ¿ »ìÆ÷ ½Ã½ºÅÛ µîÀÇ Æ®·»µå°¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¸íÈ®ÇÏ°Ô ±ÔÁ¤µÇ¾î ÀÖ¾î ¾ÈÀüÇÑ »ç¿ë°ú Á¦Çü Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå È®´ë´Â ¿¬±¸ Çù·Â°ú ÀâÃÊ ÀúÇ×¼º ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡·Î µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ±â¼ú È¿À²¼º°ú ȯ°æ ÄÄÇöóÀ̾𽺸¦ Áß¿ä½ÃÇϸç, °æÀï ȯ°æÀÌÁö¸¸ ¼º¼÷ÇÑ ½ÃÀå ȯ°æÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È Á¦ÃÊÁ¦ ³»¼º ÀÛ¹°¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀº ÀÛ¹° º¸È£ ¼Ö·ç¼Ç°ú ³ó¹ý Çö´ëÈ­¸¦ ÃËÁøÇÏ´Â Á¤ºÎÀÇ ³ë·ÂÀ¸·Î ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå¿¡¼­´Â ½Ò, Äá, ¿Á¼ö¼ö ºÎ¹®¿¡¼­ Å« ºñÁî´Ï½º ±âȸ°¡ ÀÖÀ¸¸ç, °íÇü Á¦Á¦°¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î Æ®·»µå·Î´Â Á¤¹Ð³ó¾÷ÀÇ ÅëÇÕ, À¯±â³ó¾÷ÀÇ ¿µÇâ, Çõ½ÅÀûÀÎ Àü´Þ ±â¼ú µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±¹°¡º° ±ÔÁ¦ Â÷ÀÌ, ÀúÇ×¼º °ü¸® µîÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

º» º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ±â¾÷ ¼Ò°³
    • Ãß°¡ ±â¾÷ Á¾ÇÕ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ±¸ºÐ
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­·Ð

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • ºÐ¼® ¹üÀ§
  • ºÐ¼® ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • ºÐ¼® Á¢±Ù¹ý
  • ºÐ¼® ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸ Ãâó
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ¾÷üÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëü Á¦Ç°ÀÇ À§Çù
  • ½Å±Ô ÁøÃâ ±â¾÷ÀÇ À§Çù
  • ±â¾÷°£ °æÀï

Á¦5Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : Á¾·ùº°

  • Å×Å©´ÏÄà ÄÁ¼¾Æ®·¹ÀÌÆ®(TC)
  • Å×Å©´ÏÄà µî±Þ(TK)
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : Á¦Çüº°

  • °íü
  • ¾×ü

Á¦7Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : À¯Åë ä³Îº°

  • Á÷Á¢ ÆÇ¸Å
  • ÆÇ¸Å´ë¸®Á¡
  • ¿Â¶óÀÎ ÆÇ¸Å

Á¦8Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : ¿ëµµº°

  • ÀâÃÊ ´ëÃ¥
  • ÀÛ¹° °ÇÁ¶
  • ±Û·çÆ÷½Ã³×ÀÌÆ® ³»¼º ÀÛ¹°
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½Ä¿ëÀÛ¹°
  • ȯ±ÝÀÛ¹°
  • ¿ø¿¹ÀÛ¹°
  • Ç÷£Å×ÀÌ¼Ç ÀÛ¹°
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ±Û·çÆ÷½Ã³×ÀÌÆ® ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, »ç¾÷ Á¦ÈÞ¡¤Çù·Â, ÇÕÀÛÅõÀÚ
  • ±â¾÷ ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®Àå
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Archer Daniels Midland Company(ADM)
  • BASF SE
  • Bayer AG
  • Cargill, Inc.
  • DowDuPont Inc.
  • General Mills, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Kellogg Company
  • Nestle S.A.
  • Novartis International AG
  • PepsiCo, Inc.
  • PhytoLab GmbH & Co. KG
  • Procter & Gamble Co.
  • Syngenta AG
  • The Coca-Cola Company
  • Unilever plc
KSM

According to Stratistics MRC, the Global Glufosinate Market is accounted for $3.03 billion in 2025 and is expected to reach $6.92 billion by 2032 growing at a CAGR of 12.5% during the forecast period. Glufosinate refers to a class of chemical compounds derived from glucosinolates, naturally occurring sulphur-containing compounds found in plants like mustard, broccoli, and cabbage. These compounds are primarily recognized for their bioactive properties, including pesticidal and herbicidal activities, making them valuable in agriculture and crop protection. Upon enzymatic hydrolysis, glucosinolates transform into Glufosinate and related compounds, which can inhibit the growth of pests and pathogens. Glufosinate's role spans agriculture, pharmaceuticals, and food industries, highlighting its multifunctional applications.

Market Dynamics:

Driver:

Rising demand for herbicides

Farmers are increasingly seeking effective weed control solutions to protect crop yields. Glufosinate, being a broad-spectrum herbicide, meets this demand efficiently. Expansion in agricultural activities globally further boosts its consumption. Additionally, growing awareness of sustainable and residue-free crop protection supports its adoption. Consequently, these factors collectively propel the growth of the Glufosinate market.

Restraint:

High production costs

Elevated manufacturing expenses reduce profit margins for producers, limiting investment in research and development. Small and medium-sized companies may find it difficult to compete due to the high cost barrier. High costs can also discourage farmers from adopting Glufosinate, affecting demand. Price-sensitive regions may shift to cheaper alternative herbicides. Consequently, market expansion and growth are slowed, restricting the overall market potential.

Opportunity:

Shift towards sustainable agriculture

Farmers are increasingly adopting eco-friendly herbicides to reduce environmental impact. Glufosinate, being biodegradable with low soil persistence, aligns with these sustainability goals. Demand rises as regulatory bodies promote reduced chemical residues in food and soil. Organic and integrated farming practices are encouraging the use of safer herbicide alternatives. Consequently, the market for Glufosinate is witnessing steady expansion worldwide.

Threat:

Availability of alternatives

Farmers often prefer other widely used herbicides that may be cheaper or more effective against specific weeds. These alternatives can reduce the demand for Glufosinate-based products. Additionally, established brands of competing herbicides benefit from strong market loyalty. Regulatory approvals and familiarity with other chemicals make switching easier for end-users. Overall, the presence of multiple substitutes limits Glufosinate's market growth and adoption.

Covid-19 Impact

The COVID-19 pandemic significantly disrupted the Glufosinate Market, affecting both supply chains and demand patterns. Lockdowns and restrictions led to delays in raw material production and logistics, creating temporary shortages. Agricultural and industrial sectors, key end-users, faced operational challenges, reducing immediate consumption. Additionally, shifts in government priorities toward essential healthcare and food security influenced market dynamics. Despite these setbacks, the pandemic also prompted increased interest in resilient, eco-friendly herbicides like Glufosinate. Overall, COVID-19 temporarily slowed growth but highlighted the need for adaptability and sustainable practices in the market.

The technical concentrate (TC) segment is expected to be the largest during the forecast period

The technical concentrate (TC) segment is expected to account for the largest market share during the forecast period by serving as the key raw material for formulation into end-use products like herbicides. It ensures high purity and efficacy, enhancing crop protection performance and farmer trust. TC allows flexible blending and formulation, meeting diverse agricultural needs across regions. Its production scale supports cost efficiency, making Glufosinate products more competitive globally. Continuous innovations in TC quality further expand its adoption, boosting overall market growth.

The solid formulations segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the solid formulations segment is predicted to witness the highest growth rate, due to its ease of handling, storage, and transport compared to liquid alternatives. It offers precise dosing and longer shelf life, making it attractive to farmers and distributors. Solid forms, like granules and powders, enhance application efficiency and reduce environmental runoff. This segment supports adoption in regions with limited water availability, where liquid spraying is challenging. Overall, its convenience, stability, and effectiveness significantly boost market demand and growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to high adoption of genetically modified crops. The United States, Canada, and Mexico focus on corn, soybean, and canola cultivation, creating strong demand for effective herbicides. Trends such as sustainable agriculture, integrated pest management, and automated spraying systems are shaping market growth. Regulatory frameworks are well-defined, promoting safe usage and innovation in formulations. Market expansion is also supported by research collaborations and increasing awareness of weed resistance issues. North America emphasizes technological efficiency and environmental compliance, creating a competitive yet mature market environment.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to high demand for herbicide-tolerant crops. Countries like China, India, and Japan are witnessing growth due to government initiatives promoting crop protection solutions and modernization of farming practices. The market sees significant opportunities in the rice, soybean, and corn segments, with solid formulations gaining preference. Emerging trends include precision agriculture integration, organic farming influence, and innovative delivery technologies. Challenges include regulatory variations across countries and resistance management.

Key players in the market

Some of the key players profiled in the Glufosinate Market include Archer Daniels Midland Company (ADM), BASF SE, Bayer AG, Cargill, Inc., DowDuPont Inc., Extrasynthese, General Mills, Inc., GlaxoSmithKline plc, Johnson & Johnson, Kellogg Company, Nestle S.A., Novartis International AG, PepsiCo, Inc., PhytoLab GmbH & Co. KG, Procter & Gamble Co., Syngenta AG, The Coca-Cola Company and Unilever plc.

Key Developments:

In May 2025, BASF signed an agreement with Domo to acquire the remaining 49% stake in their Alsachimie joint venture. This move strengthens BASF's position in the polyamide 6.6 value chain and expands operations at its Chalampe site in France

In May 2024, Bayer acquired the remaining 25% stake in Bayer Zydus Pharma Pvt Ltd, securing full ownership. The JV focused on pharmaceutical sales and marketing in India, covering therapies like cardiovascular, diabetes, women's health, and oncology

Types Covered:

  • Technical Concentrate (TC)
  • Technical Grade (TK)
  • Other Types

Formulations Covered:

  • Solid
  • Liquid

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Sales

Applications Covered:

  • Weed Control
  • Crop Desiccation
  • Glufosinate-Tolerant Crops
  • Other Applications

End Users Covered:

  • Food Crops
  • Cash Crops
  • Horticulture Crops
  • Plantation Crops
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Glufosinate Market, By Type

  • 5.1 Introduction
  • 5.2 Technical Concentrate (TC)
  • 5.3 Technical Grade (TK)
  • 5.4 Other Types

6 Global Glufosinate Market, By Formulation

  • 6.1 Introduction
  • 6.2 Solid
  • 6.3 Liquid

7 Global Glufosinate Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Distributors
  • 7.4 Online Sales

8 Global Glufosinate Market, By Application

  • 8.1 Introduction
  • 8.2 Weed Control
  • 8.3 Crop Desiccation
  • 8.4 Glufosinate-Tolerant Crops
  • 8.5 Other Applications

9 Global Glufosinate Market, By End User

  • 9.1 Introduction
  • 9.2 Food Crops
  • 9.3 Cash Crops
  • 9.4 Horticulture Crops
  • 9.5 Plantation Crops
  • 9.6 Other End Users

10 Global Glufosinate Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Archer Daniels Midland Company (ADM)
  • 12.2 BASF SE
  • 12.3 Bayer AG
  • 12.4 Cargill, Inc.
  • 12.5 DowDuPont Inc.
  • 12.6 General Mills, Inc.
  • 12.7 GlaxoSmithKline plc
  • 12.8 Johnson & Johnson
  • 12.9 Kellogg Company
  • 12.10 Nestle S.A.
  • 12.11 Novartis International AG
  • 12.12 PepsiCo, Inc.
  • 12.13 PhytoLab GmbH & Co. KG
  • 12.14 Procter & Gamble Co.
  • 12.15 Syngenta AG
  • 12.16 The Coca-Cola Company
  • 12.17 Unilever plc
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦